iBio, Inc. Research And Development Expense

• iBio, Inc. showed an increase of +60.3% in Research And Development Expense from 2024 to 2025.
• This data is from iBio, Inc.'s annual report (Form 10-K), filed with the SEC on September 5, 2025.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 14 years of available data (2012 to 2025), iBio, Inc.'s Research And Development Expense has grown by 66.9%.
• Historical annual values: Fiscal year 2025: $8.31 million | Fiscal year 2024: $5.19 million | Fiscal year 2023: $10.33 million | Fiscal year 2022: $9.83 million | Fiscal year 2021: $9.99 million | Fiscal year 2020: $3.57 million | Fiscal year 2019: $5.47 million | Fiscal year 2018: $3.99 million | Fiscal year 2017: $4.12 million | Fiscal year 2016: $3.16 million | Fiscal year 2015: $3.50 million | Fiscal year 2014: $1.90 million | Fiscal year 2013: $3.43 million | Fiscal year 2012: $4.98 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026